Completed PHASE2 INTERVENTIONAL 1-arm NCT01464138

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children

Sponsor: Fundacio Clinic Barcelona

Conditions Malaria

Interventions Fosmidomycin and Clindamycin co-administration

Updated 6 times since 2017 Last updated: Nov 2, 2011 Started: Sep 30, 2010 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Malaria and is currently completed. Fundacio Clinic Barcelona leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Oct 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Oct 2020 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacio Clinic Barcelona
Hospital Clinic of Barcelona
Jomaa Pharma GmbH

Data source: Jomaa Pharma GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maputo, Mozambique